Protection of enzymes by α-crystallin acting as a molecular chaperone

International Journal of Biological Macromolecules

Volumn 22, Issue 3-4, 1998, Pages 295-306

  Hook, D W A ^a   Harding, J J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Chaperone; Glycation; crystallin

Indexed keywords

ALPHA CRYSTALLIN; CHAPERONE; CYANIC ACID; LENS PROTEIN; STEROID; SUGAR; SUGAR PHOSPHATE;

ARTICLE; CATARACT; COMPLEX FORMATION; DIABETES MELLITUS; DIARRHEA; ENZYME ACTIVITY; ENZYME INACTIVATION; GLYCATION; HUMAN; HYPOTHESIS; KIDNEY FAILURE; PROTEIN BINDING; RISK FACTOR; STOICHIOMETRY;

EID: 0032078109     PISSN: 01418130     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0141-8130(98)00027-0     Document Type: Article

References (61)

1. Ingolia T.D., Craig E.A. Proc Natl Acad Sci USA. 79:1982;2360.
2. Horwitz J. Proc Natl Acad Sci USA. 89:1992;10449.
3. Bhat S.P., Nagineni C.N. Biochem Biophys Res Commun. 158:1989;319.
4. Iwaki T., Kume Iwaki A., Liem R.K., Goldman J.E. Cell. 57:1989;71.
5. Iwaki T., Kume Iwaki A., Goldman J.E. J Histochem Cytochem. 38:1990;31.
6. Kato K., Shinohara H., Kurobe N., Goto S., Inaguma Y., Ohshima K Biochim Biophys Acta. 1080:1991;173.
7. Srinivasan A.N., Nagineni C.N., Bhat S.P. J Biol Chem. 267:1992;23337.
8. Merck K.B., Groenen P.J., Voorter C.E., de Haard Hoekman W.A., Horwitz J., Bloemendal H., de Jong W.W. J Biol Chem. 268:1993;1046.
9. Beswick H.T., Harding J.J. Biochem J. 246:1987;761.
10. Beswick H.T., Harding J.J. Biochem J. 223:1984;221.
11. Beswick H.T., Harding J.J. Exp Eye Res. 45:1987;569.
12. Blakytny R., Harding J.J. Biochem J. 288:1992;303.
13. Ganea E., Harding J.J. Biochem Soc Trans. 22:1994;445S.
14. Harding JJ, Cataract. Biochemistry, Epidemiology and Pharmacology. Chapman and Hall, London, 1991:1-333.
15. Jedziniak J.A., Chylack L.T. Jr., Cheng H.-M., Gillis M.K., Kalustian A.A., Tung W.H. Invest Ophthalmol Vis Sci. 20:1981;314.
16. Bunn H.F., Higgins P.J. Science. 213:1981;222.
17. Blakytny R., Harding J.J. Exp Eye Res. 64:1997;1051.
18. Ganea E., Harding J.J. Eur J Biochem. 231:1995;181.
19. Yar H, Harding JJ Biochem J. 328:1997;599-605.
20. Blakytny R., Harding J.J. Biochem Soc Trans. 23:1995;610S.
21. Blakytny R., Harding J.J. Ophthalmic Res. 28:1996;19.
22. Heath M.M., Rixon K.C., Harding J.J. Biochim Biophys Acta. 1315:1996;176.
23. Derham BK, Harding JJ Biochim Biophys Acta. 1336:1997;187-194.
24. Derham BK, Harding JJ Biochem J. 328:1997;763-768.
25. Black R.L., Oglesby R.B., von Sallmann L., Bunim J.J. J Am Med Assoc. 177:1960;166.
26. Harding J.J., van Heyningen R. Br J Ophthalmol. 72:1988;809.
27. Leske M.C., Chylack L.T. Jr., Wu S.Y. Arch Ophthalmol. 109:1991;244.
28. Bucala R., Gallati M., Manabe S., Cotlier E., Cerami A. Exp Eye Res. 40:1985;853.
29. Nishigori H., Lee J.W., Yamauchi Y., Maruyama K., Iwatsuru M. Invest Ophthalmol Vis Sci. 28:1987;168.
30. Shui Y.B., Kojima M., Sasaki K. Ophthalmic Res. 28:1996;92.
31. Manabe S., Bucala R., Cerami A.J. Clin Invest. 74:1984;1803.
32. Hook D.W.A., Harding J.J. FEBS Lett. 382:1996;281.
33. Harding J.J., Rixon K.C. Exp Eye Res. 31:1980;567.
34. Ganea E., Harding J.J. Biochem Biophys Res Commun. 222:1996;626.
35. Carver J.A., Aquilina J.A., Truscott R.J. Exp Eye Res. 59:1994;231.
36. Wang K., Spector A. J Biol Chem. 269:1994;13601.
37. Raman B., Ramakrishna T., Rao C.M. FEBS Lett. 365:1995;133.
38. Wang K., Spector A. Invest Ophthalmol Vis Sci. 36:1995;211.
39. Horwitz J. Invest Ophthalmol Vis Sci. 34:1993;10.
40. Raman B., Rao C.M. J Biol Chem. 269:1994;27264.
41. Surewicz W.K., Olesen P.R. Biochemistry. 34:1995;9655.
42. Hockwin O., Ohrloff C. Bloemendal H. Molecular and Cellular Biology of the Eye. 1981;367 Wiley, New York.
43. Jakob U., Gaestel M., Engel K., Buchner J. J Biol Chem. 268:1993;1517.
44. Lee G.J., Pokala N., Vierling E. J Biol Chem. 270:1995;10432.
45. Hook D.W.A., Harding J.J. Eur J Biochem. 247:1997;380.
46. Horwitz J., Emmons T., Takemoto L. Curr Eye Res. 11:1992;817.
47. Cherian M., Abraham E.C. Biochem Biophys Res Commun. 208:1995;675.
48. Cherian M., Abraham E.C. Biochem Biophys Res Commun. 212:1995;184.
49. Carver J.A., Nicholls K.A., Aquilina J.A., Truscott R.J. Exp Eye Res. 63:1996;639.
50. Harding J.J., Crabbe M.J.C. Davson H. The Eye. IB:1984;207 Academic Press, London.
51. van Boekel M.A.M., Hoogakker S.E., Harding J.J., de Jong W.W. Ophthalmic Res. 28:1996;32.
52. Blakytny R, Carver JA, Harding JJ, Kilby GW, Sheil MM Biochim Biophys Acta. 1343:1997;299-315.
53. Smulders R.H.P.H., Carver J.A., Lindner R.A., van Boekel M.A.M., Bloemendal H., de Jong W.W. J Biol Chem. 271:1996;29060.
54. Ajiboye R., Harding J.J. Exp Eye Res. 49:1989;31.
55. Augusteyn R.C., Koretz J.F. FEBS Lett. 222:1987;1.
56. Singh K., Groth Vasselli B., Kumosinski T.F., Farnsworth P.N. FEBS Lett. 372:1995;283.
57. Rao P.V., Horwitz J., Zigler J.S. Jr. Biochem Biophys Res Commun. 190:1993;786.
58. Wiech H., Buchner J., Zimmermann R., Jakob U. Nature. 358:1992;169.
59. Jakob U., Lilie H., Meyer I., Buchner J. J Biol Chem. 270:1995;7288.
60. Buchner J. FASEB J. 10:1996;10.
61. Jedziniak J.A., Arredondo L.M., Meys M. Curr Eye Res. 5:1986;119.